Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study

M. A. Cavender; A. Norhammar; K. I. Birkeland; M. E. Jorgensen; P. Wilding; K. Khunti; A. Z. Fu; J. Bodegard; B. Blak; E. T. Wittbrodt; M. Thuresson; P. Fenici; N. Hammar; M. Kosiborod; CVD-REAL Investigators StudyGrp

Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study

M. A. Cavender, A. Norhammar, K. I. Birkeland, M. E. Jorgensen, P. Wilding, K. Khunti, A. Z. Fu, J. Bodegard, B. Blak, E. T. Wittbrodt, M. Thuresson, P. Fenici, N. Hammar, M. Kosiborod, CVD-REAL Investigators StudyGrp

Originalsprog	Udefineret/Ukendt
Tidsskrift	Diabetologia
Vol/bind	60
Udgave nummer	1
Sider (fra-til)	S41
ISSN	0012-186X
Status	Udgivet - 1 sep. 2017
Begivenhed	53rd Annual Meeting of the European Association for the study of Diabetes EASD - International Fair of Lisbon and MEO Arena, Rua do Bojador, Parque das Nações, Lisabon, Portugal Varighed: 11 sep. 2017 → 15 sep. 2017 https://www.easd.org/annual-meeting/easd-2017.html

Konference

Konference	53rd Annual Meeting of the European Association for the study of Diabetes EASD
Lokation	International Fair of Lisbon and MEO Arena, Rua do Bojador, Parque das Nações
Land/Område	Portugal
By	Lisabon
Periode	11/09/2017 → 15/09/2017
Internetadresse	https://www.easd.org/annual-meeting/easd-2017.html

Adgang til dokumentet

https://www.easd.org/virtualmeeting/home.html#!resources/hospitalisation-for-heart-failure-and-death-in-new-users-of-sglt-2-inhibitors-in-patients-with-and-without-cardiovascular-disease-the-cvd-real-study

Citationsformater

Cavender, M. A., Norhammar, A., Birkeland, K. I., Jorgensen, M. E., Wilding, P., Khunti, K., Fu, A. Z., Bodegard, J., Blak, B., Wittbrodt, E. T., Thuresson, M., Fenici, P., Hammar, N., Kosiborod, M., & StudyGrp, CVD.-REAL. I. (2017). Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study. Diabetologia, 60(1), S41. https://www.easd.org/virtualmeeting/home.html#!resources/hospitalisation-for-heart-failure-and-death-in-new-users-of-sglt-2-inhibitors-in-patients-with-and-without-cardiovascular-disease-the-cvd-real-study

Cavender, MA, Norhammar, A, Birkeland, KI, Jorgensen, ME, Wilding, P, Khunti, K, Fu, AZ, Bodegard, J, Blak, B, Wittbrodt, ET, Thuresson, M, Fenici, P, Hammar, N, Kosiborod, M & StudyGrp, CVD-REALI 2017, 'Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study', Diabetologia, bind 60, nr. 1, s. S41. <https://www.easd.org/virtualmeeting/home.html#!resources/hospitalisation-for-heart-failure-and-death-in-new-users-of-sglt-2-inhibitors-in-patients-with-and-without-cardiovascular-disease-the-cvd-real-study>

@article{7be95e726bdd41f286d3721dcb195d1d,

title = "Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study",

author = "Cavender, {M. A.} and A. Norhammar and Birkeland, {K. I.} and Jorgensen, {M. E.} and P. Wilding and K. Khunti and Fu, {A. Z.} and J. Bodegard and B. Blak and Wittbrodt, {E. T.} and M. Thuresson and P. Fenici and N. Hammar and M. Kosiborod and StudyGrp, {CVD-REAL Investigators}",

note = "53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon, PORTUGAL, SEP 11-15, 2017; 53rd Annual Meeting of the European Association for the study of Diabetes EASD ; Conference date: 11-09-2017 Through 15-09-2017",

year = "2017",

month = sep,

day = "1",

language = "Udefineret/Ukendt",

volume = "60",

pages = "S41",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "1",

url = "https://www.easd.org/annual-meeting/easd-2017.html",

}

TY - JOUR

T1 - Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVDREAL study

AU - Cavender, M. A.

AU - Norhammar, A.

AU - Birkeland, K. I.

AU - Jorgensen, M. E.

AU - Wilding, P.

AU - Khunti, K.

AU - Fu, A. Z.

AU - Bodegard, J.

AU - Blak, B.

AU - Wittbrodt, E. T.

AU - Thuresson, M.

AU - Fenici, P.

AU - Hammar, N.

AU - Kosiborod, M.

AU - StudyGrp, CVD-REAL Investigators

N1 - 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon, PORTUGAL, SEP 11-15, 2017

PY - 2017/9/1

Y1 - 2017/9/1

M3 - Tidsskriftartikel

SN - 0012-186X

VL - 60

SP - S41

JO - Diabetologia

JF - Diabetologia

IS - 1

T2 - 53rd Annual Meeting of the European Association for the study of Diabetes EASD

Y2 - 11 September 2017 through 15 September 2017

ER -